These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38046095)

  • 21. Deficiency of Murine UFM1-Specific E3 Ligase Causes Microcephaly and Inflammation.
    Zhang J; Zhu H; Liu S; Quintero M; Zhu T; Xu R; Cai Y; Han Y; Li H
    Mol Neurobiol; 2022 Oct; 59(10):6363-6372. PubMed ID: 35931931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zebrafish: a model vertebrate suitable for the analysis of human genetic disorders.
    Ota S; Kawahara A
    Congenit Anom (Kyoto); 2014 Feb; 54(1):8-11. PubMed ID: 24279334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic editing opens new avenues for zebrafish as a model for neurodegeneration.
    Schmid B; Haass C
    J Neurochem; 2013 Nov; 127(4):461-70. PubMed ID: 24117801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An N-Terminal Extension to UBA5 Adenylation Domain Boosts UFM1 Activation: Isoform-Specific Differences in Ubiquitin-like Protein Activation.
    Soudah N; Padala P; Hassouna F; Kumar M; Mashahreh B; Lebedev AA; Isupov MN; Cohen-Kfir E; Wiener R
    J Mol Biol; 2019 Feb; 431(3):463-478. PubMed ID: 30412706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A selective inhibitor of the UFM1-activating enzyme, UBA5.
    da Silva SR; Paiva SL; Bancerz M; Geletu M; Lewis AM; Chen J; Cai Y; Lukkarila JL; Li H; Gunning PT
    Bioorg Med Chem Lett; 2016 Sep; 26(18):4542-4547. PubMed ID: 27520940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. UFMylation System: An Emerging Player in Tumorigenesis.
    Jing Y; Mao Z; Chen F
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Knockout of zebrafish interleukin 7 receptor (IL7R) by the CRISPR/Cas9 system delays retinal neurodevelopment.
    Cai S; Chen Y; Shang Y; Cui J; Li Z; Li Y
    Cell Death Dis; 2018 Feb; 9(3):273. PubMed ID: 29449560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization, crystallization and preliminary X-ray crystallographic analysis of the Uba5 fragment necessary for high-efficiency activation of Ufm1.
    Xie S
    Acta Crystallogr F Struct Biol Commun; 2014 Jun; 70(Pt 6):765-8. PubMed ID: 24915089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Essential Role of Ubiquitin-Fold Modifier 1 Conjugation in DNA Damage Response.
    Fang Z; Pan Z
    DNA Cell Biol; 2019 Oct; 38(10):1030-1039. PubMed ID: 31368785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel insights into the interaction of UBA5 with UFM1 via a UFM1-interacting sequence.
    Padala P; Oweis W; Mashahreh B; Soudah N; Cohen-Kfir E; Todd EA; Berndsen CE; Wiener R
    Sci Rep; 2017 Mar; 7(1):508. PubMed ID: 28360427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging role of protein modification by UFM1 in cancer.
    Chung CH; Yoo HM
    Biochem Biophys Res Commun; 2022 Dec; 633():61-63. PubMed ID: 36344165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging role of UFMylation in secretory cells involved in the endocrine system by maintaining ER proteostasis.
    Cheng Y; Niu Z; Cai Y; Zhang W
    Front Endocrinol (Lausanne); 2022; 13():1085408. PubMed ID: 36743909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A zebrafish model of CLN2 disease is deficient in tripeptidyl peptidase 1 and displays progressive neurodegeneration accompanied by a reduction in proliferation.
    Mahmood F; Fu S; Cooke J; Wilson SW; Cooper JD; Russell C
    Brain; 2013 May; 136(Pt 5):1488-507. PubMed ID: 23587805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clustered regularly interspaced short palindromic repeats as an advanced treatment for Parkinson's disease.
    Mehmood A; Ali W; Din ZU; Song S; Sohail M; Shah W; Guo J; Guo RY; Ilahi I; Shah S; Al-Shaebi F; Zeb L; Asiamah EA; Al-Dhamin Z; Bilal H; Li B
    Brain Behav; 2021 Aug; 11(8):e2280. PubMed ID: 34291612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. UFMylation: A Unique & Fashionable Modification for Life.
    Wei Y; Xu X
    Genomics Proteomics Bioinformatics; 2016 Jun; 14(3):140-146. PubMed ID: 27212118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Generation of Zebrafish Mariner Model Using the CRISPR/Cas9 System.
    Zou B; Desmidt AA; Mittal R; Yan D; Richmond M; Tekin M; Liu XZ; Lu Z
    Anat Rec (Hoboken); 2020 Mar; 303(3):556-562. PubMed ID: 31260171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome Editing in Zebrafish Using CRISPR-Cas9: Applications for Developmental Toxicology.
    Warner BK; Alder JK; Suli A
    Methods Mol Biol; 2019; 1965():235-250. PubMed ID: 31069679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. UFL1, a UFMylation E3 ligase, plays a crucial role in multiple cellular stress responses.
    Jiang Q; Wang Y; Xiang M; Hua J; Zhou T; Chen F; Lv X; Huang J; Cai Y
    Front Endocrinol (Lausanne); 2023; 14():1123124. PubMed ID: 36843575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome editing using artificial site-specific nucleases in zebrafish.
    Hisano Y; Ota S; Kawahara A
    Dev Growth Differ; 2014 Jan; 56(1):26-33. PubMed ID: 24117409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure and dynamics of UBA5-UFM1 complex formation showing new insights in the UBA5 activation mechanism.
    Fuchs S; Kikhney AG; Schubert R; Kaiser C; Liebau E; Svergun DI; Betzel C; Perbandt M
    J Struct Biol; 2021 Dec; 213(4):107796. PubMed ID: 34508858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.